PTH and Marchiafava-Bignami disease: Guide non-active and active vitamin D therapy by individual CKD-MBD parameters (PTH, Ph, AP, Ca, and bone-specific AP), enable adequate bone turnover without over suppression of PTH with risks of ABD.